Molecular signaling in response to high glucose in endothelial cells. by Haroldo A. Toque (447341)

Genes with highest fold change in exponential compared to stationary phase. Genes with >10 fold enrichment are shown, ribosomal genes are highlighted with bolded text. <i>rpsJ</i>/... by Justin Greene (306625)

Log fold changes of genes involved in regulation of the complement pathway in the left ventricle [22] correspond to increased expression of pro-complement activation genes and decr... by Nicholas Markarian (18251668)

“…<p>Log fold changes of genes involved in regulation of the complement pathway in the left ventricle [<a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1011968#pcbi.1011968.ref022" target="_blank">22</a>] correspond to increased expression of pro-complement activation genes and decreased expression of inhibitors.…”

Mean and standard deviation of 5-point experience sampling scales for each group (treatment and control) and session (pre and post). by Julio Rodriguez-Larios (18778803)

Selection of the 25 candidate unigenes most up-regulated and the 25 candidate unigenes most down-regulated of IAC Imperador (decreasing order of log2FoldChange). by Daiana Alves da Silva (5529677)

Metabolite concentrations decrease to near-uninfected levels after treatment of infection. by Derick N. M. Osakunor (4839597)

Leukocyte infiltration <i>in vivo</i> is decreased by CLEC9A inhibition with H37Ra. by An-Chieh Cheng (4532641)

Percentage decrease in the response time (mean ± std) in the post-training test phase when compared to that in the pre-training phase. by Lilian Fautrelle (711885)

PowerPoint Slides for: Plasma Exchange as an Adjunctive Therapy for Crescentic IgA Nephropathy by Xie X. (2945913)

“…It also significantly decreased plasma IgA-IgG complex levels (pre-PE: 85.3 ± 25.9% vs. post-PE: 38.4 ± 12.4%, p < 0.001) and plasma and urinary active complement product levels, including C3a, C5a and soluble C5b-9. …”

Effects of tolvaptan on brain water content (BWC), plasma and urine sodium and osmolality. by Emil Zeynalov (596088)

Metalloproteinase gene expression at different time points expressed as ΔCt. by Fabíola S. Z. Robertoni (751356)

Effects of conivaptan on brain water content (BWC), blood-brain-barrier (BBB) disruption, plasma and urine sodium and osmolality. by Emil Zeynalov (596088)

“…Following MCAO, Evans Blue (EB) extravasation index (I/C) was increased in vehicle treated mice, and reduced in conivaptan treated mice, naïve, n = 5, vehicle, n = 8, Conivaptan 0.2 mg, n = 8. (C, D) Conivaptan treatment of 0.2 mg resulted in an elevation of plasma sodium and osmolality, and decreased urine sodium and osmolality due to aquaresis. …”

A Point Mutation in a Herpesvirus Polymerase Determines Neuropathogenicity by Laura B Goodman (80305)

Fli-1 directly activates miR-17-92 promoter and contributes to miR-17 and miR-20a expression in NN10#5 cells. by Samer Kayali (133888)

“…<p>A: NN10#5 cells have been cultured for two days in absence or presence of Dox used to induce Fli-1 knock-down before analysis. …”

P-V Fit Scores Across Demographic Factors Among 636 residents. by Yaotian Fan (5917766)

Subjects:

Formation of shorter endogenous coding joints in mouse pro-B cells overexpressing Lig-37. by Vidyasagar Malashetty (14676064)

Chimeric protein Lig-37 supports formation of coding joints. by Vidyasagar Malashetty (14676064)

“…White arrows within the graph highlight the mean value for each set of data points.</p>…”

Domain-peptide binding as a minimal example of coupled folding and binding. by Iskra Staneva (135380)

Conduction slowing at branching points. by Tanmay A. Gokhale (3687244)

“…An up to 36.6% decrease in local conduction velocity leads to a conduction delay across the branch point (middle panel) and a net 11.8% reduction in mean CV along the strand (bottom panel, dashed). …”

<i>Drosophila</i> Trabid significantly decreases K63-linked polyubiquitination in dTAK1 through its catalytic C518 and NZF domains. by Merennege Dilan Anush Fernando (525297)